U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07733466) titled 'Open-Label Neoadjuvant Pembrolizumab Plus Cetuximab in Betel Nut-Associated Locally Advance... Read More
Singapore, July 30 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... Read More
Singapore, July 30 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... Read More
Singapore, July 30 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability ... Read More
U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07733401) titled 'Guided Laminectomy With Augmented Duroplasty for Acute Traumatic Spinal Cord Injury' on Jul... Read More
Singapore, July 30 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab... Read More
Singapore, July 30 -- The Health Sciences Authority received information related to the study titled 'A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety o... Read More
U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07735052) titled 'Drug-drug Interaction Study Between UIC202304, and UIC202305' on July 21. Brief Summary: A... Read More
U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07733518) titled 'Eccentric vs Low-Load Blood Flow Restriction Training in Knee Osteoarthritis in Knee Osteoa... Read More
U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07734675) titled 'Sociocognitive Intervention and Rehabilitation Program in Multiple Sclerosis' on July 14. ... Read More